Hamid Erfanian - Jun 15, 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role
Chief Executive Officer
Signature
/s/ Hamid Erfanian
Stock symbol
ENZ
Transactions as of
Jun 15, 2022
Transactions value $
$10,074
Form type
4
Date filed
6/17/2022, 04:31 PM
Previous filing
Apr 14, 2022
Next filing
Nov 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENZ Common Stock, $0.01 Par Value Purchase $10.1K +4.6K +1.7% $2.19 275K Jun 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENZ Stock Option (to acquire Common Stock) Award $0 +700K $0.00 700K Nov 8, 2021 Common Stock 700K $3.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.